Position in ARVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,789,516
-$3,915,944 QoQ
Shares Held
215,345
-67.8% QoQ
Ownership
0.329%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 198 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. ARVN ranks #144 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ARVN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,789,516 | 215,345 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $5,705,460 | 669,655 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,937,652 | 1,214,355 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $928,746 | 132,300 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,320,813 | 68,900 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,556,572 | 144,400 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,331,148 | 275,400 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $14,942,245 | 361,973 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,778,504 | 237,573 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,233,068 | 113,700 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,514,512 | 141,600 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,335,948 | 48,900 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $757,620 | 18,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,775,920 | 130,400 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,236,752 | 136,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,820,940 | 83,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $14,106,400 | 183,200 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $15,368,250 | 232,500 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $7,864,518 | 92,600 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $3,102,450 | 92,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,885,948 | 220,495 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||